布西拉明

布西拉明（CAS 65002-17-7）的公开数据库记录，列此仅供独立核对。

这个物质在各数据库里的编号

数据库记载的用途

• Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.
• Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues.
• M01 - Antiinflammatory and antirheumatic products
• M01C - Specific antirheumatic agents
• M01CC - Penicillamine and similar agents
• QM01 - Antiinflammatory and antirheumatic products

它在各数据库里的别名

bucillamine; 65002-17-7; Tiobutarit; Bucilant; Bucilamina; N-(2-Mercapto-2-methylpropionyl)-L-cysteine; Bucillaminum; DTXSID2048587; R80LRA5WTF; SA-96; DE019; L-CYSTEINE, N-(2-MERCAPTO-2-METHYL-1-OXOPROPYL)-; (2R)-2-(2-METHYL-2-SULFANYLPROPANAMIDO)-3-SULFANYLPROPANOIC ACID; DTXCID2028513; RefChem:917687; M01CC02

计算机算出的分子描述符

数据库摘要

bucillamine · CAS 65002-17-7 · C7H13NO3S2. UNII R80LRA5WTF.

数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。